NEWYou can now listen to Fox News articles! Psilocybin, the main psychoactive ingredient in magic mushrooms, could alleviate depression for at least five years after just one dose, according to a new study. The research, presented June 18 at the Psychedelic Science 2025 conference in Denver, followed up with patients who had been diagnosed with clinical depression — also known …
Read More »
NEWYou can now listen to Fox News articles! An experimental weight-loss medication was shown to help people lose nearly 25% of their body weight in early-stage 1a/2b trials. The drug, amycretin — developed by Novo Nordisk — works by replicating two hunger hormones — amylin, which regulates appetite and creates a feeling of fullness, and glucagon-like peptide 1 (GLP-1), the …
Read More »
NEWYou can now listen to Fox News articles! Diabetes is the leading cause of vision loss in people between 18 and 64 years old, according to the American Diabetes Association — and the best way to prevent this is to control blood sugar levels. Glucagon-like peptide-1 receptor agonists (GLP-1s), such as Ozempic and Mounjaro, have become popular medications for controlling …
Read More »
< div class=”featured featured-video video-ct” data-v-5f342d4c> < div class=”contain” data-v-5f342d4c> <!–> FDA authorizes AI tool to predict breast cancer risk Senior medical analyst Dr. Marc Siegel discusses advancements in artificial intelligence aimed at predicting an individual’s future risk of breast cancer and the increased health risks from cannabis as users age. NEWYou can now listen to Fox News articles! The …
Read More »
NEWYou can now listen to Fox News articles! Your genetic makeup could be the reason you’re not losing weight. New research from Harvard T.H. Chan School of Public Health and Ben Gurion University in Israel found that one-third of people who followed a healthy diet did not lose any weight — although they did experience health benefits. Participants exhibited “significant …
Read More »
NEWYou can now listen to Fox News articles! Weight-loss surgery was shown to be five times more effective than weekly injections of popular GLP-1 receptor agonists, including semaglutide (such as Ozempic) and tirzepatide (such as Mounjaro). The finding comes from a recent study presented this week at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting …
Read More »
NEWYou can now listen to Fox News articles! Most households have a stash of painkillers tucked away for surprise headaches or stubborn cramps. But some may not realize that all painkillers are not created equal, and they don’t all treat the same kind of pain. Types of pain relievers Over-the-counter (OTC) pain relievers fall into two main categories, according to …
Read More »
NEWYou can now listen to Fox News articles! A new daily pill could provide an easier, more convenient way to lower cholesterol and reduce heart attack and stroke risk. The experimental medication, called Obicetrapib, underwent a Phase 3 clinical trial at Monash University in Australia. The trial included more than 2,500 people averaging 65 years of age. All had either …
Read More »
NEWYou can now listen to Fox News articles! Side effects from GLP-1s can vary — but one lesser-known reported outcome of the popular weight-loss medications is hair loss or thinning. Some hairstylists have confirmed an uptick in clients who complain about losing hair while on weight-loss journeys. This includes Ashley DiMatteo, owner of Ashley Lauren Beauty Lounge in Westchester, New …
Read More »
NEWYou can now listen to Fox News articles! Weight-loss drugs continue to grow in popularity, with market researchers predicting that global demand for the medications could reach $150 billion by 2035. GLP-1 agonists — including semaglutides like Ozempic and Wegovy and tirzepatides like Mounjaro and Zepbound — are intended to treat type 2 diabetes and obesity. Recent studies, however, have …
Read More »
tvt news Haberler